Tamgiblimab

Tax included
Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects.
MedChemExpress 
HY-P99508

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
2411914-36-6